Registration Dossier

Diss Factsheets

Administrative data

Description of key information

No repeated dose studies for p-tolyl isocyanate are available.

Key value for chemical safety assessment

Repeated dose toxicity: via oral route - systemic effects

Endpoint conclusion
Endpoint conclusion:
no study available

Repeated dose toxicity: inhalation - systemic effects

Endpoint conclusion
Endpoint conclusion:
no study available

Repeated dose toxicity: inhalation - local effects

Endpoint conclusion
Endpoint conclusion:
no study available

Repeated dose toxicity: dermal - systemic effects

Endpoint conclusion
Endpoint conclusion:
no study available

Repeated dose toxicity: dermal - local effects

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

p-tolyl isocyanate shall be registrated according REACH Article 18 (transported isolated intermediate) and no studies are required according REACH Annex VII.

Justification for classification or non-classification

no studies available